Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GALCANEZUMAB-GNLM vs GATIFLOXACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GALCANEZUMAB-GNLM vs GATIFLOXACIN: Safety Overview

Metric GALCANEZUMAB-GNLM GATIFLOXACIN
Total FAERS Reports 26,722 341
Deaths Reported 66 7
Death Rate 0.2% 2.1%
Hospitalizations 681 30
Average Patient Age 47.4 yrs 62.5 yrs
% Female Patients 87.6% 76.2%
FDA Approval Date N/A Aug 19, 2011
Manufacturer N/A Allergan, Inc.
Route N/A OPHTHALMIC
Marketing Status Prescription Discontinued